Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease macular degeneration
Symptom C0339546|retinal pigment epithelial detachment
Sentences 4
PubMedID- 23819839 Purpose: the aim of the study was to identify predictive factors for detection of impending retinal pigment epithelium (rpe) tears in patients under anti-vegf therapy for treatment of retinal pigment epithelial detachment (ped) due to exudative age-related macular degeneration (amd) using near-infrared reflectance imaging (nir), spectral-domain optical coherence tomography (sd-oct) and fluorescein angiography (fla).
PubMedID- 23558214 Purpose: the aim of this study is to report the short-term efficacy of aflibercept in the treatment of neovascular age-related macular degeneration (amd) with associated retinal pigment epithelial detachment (ped) which is refractory or develops tachyphylaxis to bevacizumab and ranibizumab.
PubMedID- 25277305 Summary statement: intravitreal high dose (2 mg) ranibizumab may lead to quicker resolution of choroidal neovascularization (cnv) and associated retinal pigment epithelial detachment in eyes with exudative age-related macular degeneration, although it may possibly correlate with rpe tears in certain cases.
PubMedID- 22207117 Retinal pigment epithelial tears following ranibizumab therapy for fibrovascular retinal pigment epithelial detachment due to occult age-related macular degeneration.

Page: 1